Phospholipids modulate the biophysical properties and vasoactivity of PACAP-(1—38)
- 1 October 2002
- journal article
- Published by American Physiological Society in Journal of Applied Physiology
- Vol. 93 (4), 1377-1383
- https://doi.org/10.1152/japplphysiol.00277.2002
Abstract
The purpose of this study was to elucidate the interactions between pituitary adenylate cyclase-activating peptide (PACAP)-(1—38) and phospholipids in vitro and to determine whether these phenomena modulate, in part, the vasorelaxant effects of the peptide in the intact peripheral microcirculation. We found that the critical micellar concentration of PACAP-(1—38) was 0.4–0.9 μM. PACAP-(1—38) significantly increased the surface tension of a dipalmitoylphosphatidylcholine monolayer and underwent conformational transition from predominantly random coil in saline to α-helix in the presence of distearoyl-phosphatidylethanolamine-polyethylene glycol (molecular mass of 2,000 Da) sterically stabilized phospholipid micelles (SSM) ( P < 0.05). Using intravital microscopy, we found that aqueous PACAP-(1—38) evoked significant concentration-dependent vasodilation in the intact hamster cheek pouch that was significantly potentiated when PACAP-(1—38) was associated with SSM ( P < 0.05). The vasorelaxant effects of aqueous PACAP-(1—38) were mediated predominantly by PACAP type 1 (PAC1) receptors, whereas those of PACAP-(1—38) in SSM predominantly by PACAP/vasoactive intestinal peptide type 1 and 2 (VPAC1/VPAC2) receptors. Collectively, these data indicate that PACAP-(1—38) self-associates and interacts avidly with phospholipids in vitro and that these phenomena amplify peptide vasoactivity in the intact peripheral microcirculation.Keywords
This publication has 34 references indexed in Scilit:
- Secretin self-assembles and interacts spontaneously with phospholipids in vitroPeptides, 2002
- Detection of VIP receptors in MNU-induced breast cancer in rats: implications for breast cancer targeting.Breast Cancer Research and Treatment, 2001
- Evidence for roles of vasoactive intestinal polypeptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) receptors in modulating the responses of rat dorsal horn neurons to sensory inputsNeuropeptides, 1997
- Cloning and Functional Characterization of the Human Vasoactive Intestinal Peptide (VIP)-2 ReceptorBiochemical and Biophysical Research Communications, 1995
- Short-term exposure to lipopolysaccharide is associated with microvascular contractile dysfunction in vivoLife Sciences, 1995
- Vasoactive intestinal peptide encapsulated in liposomes: Effects on systemic arterial blood pressureLife Sciences, 1994
- Human Intestinal VIP Receptor: Cloning and Functional Expression of Two cDNA Encoding Proteins with Different N-Terminal DomainsBiochemical and Biophysical Research Communications, 1994
- Endothelium-dependent and endothelium-independent vasodilatation of the hepatic artery of the rabbitBritish Journal of Pharmacology, 1991
- Microvascular pressure distribution and responses of pulmonary allografts and cheek pouch arterioles in the hamster to oxygen.Circulation Research, 1981
- A preferred conformation in the vasoactive intestinal peptide (VIP). Molecular architecture of gastrointestinal hormonesBioorganic Chemistry, 1974